Gene · 54894
Papers2,200
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,200
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation. | Sci Adv | 2026 | 42777043 | PubTator, text mining | PubMed |
| Clinicopathologic Features, Treatment Patterns, and Outcomes of Microsatellite Instability-High Gastric and Gastroesophageal Junction Adenocarcinoma: A Single-Institution Retrospective Analysis. | JCO Precis Oncol | 2026 | 42753221 | PubTator, text mining | PubMed |
| RNF research trends and an RNF43-based prognostic model for colorectal cancer with immune microenvironment analysis. | Discov Oncol | 2026 | 42671492 | PubTator, text mining | PubMed |
NECTIN4 (PVRL4) expression in pancreatic cancer patients might be associated with a more unfavorable prognosis, independent of age at diagnosis, sex, and stage: A public microarray and RNA sequencing data based bioinformatics analysis. | Comput Biol Chem | 2026 | 42567085 | PubTator, text mining | PubMed |
| Deletion of the Wnt regulator Znrf3 alters bone geometry without inducing high bone mass. | Bone | 2026 | 42520949 | PubTator, text mining | PubMed |
| Artificial Intelligence-Enabled Analysis of WNT Pathway Dysregulation in Bevacizumab-Treated Early-Onset Colorectal Cancer. | Int J Mol Sci | 2026 | 42511540 | PubTator, text mining | PubMed |
| Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas: History, Myths, and Realities Between Past and Future. | Med Sci (Basel) | 2026 | 42506374 | PubTator, text mining | PubMed |
| SOMATIC MUTATION PROFILES IN COLORECTAL CANCERS DIFFER BY POPULATION. | medRxiv | 2026 | 42428056 | PubTator, text mining | PubMed |
| ZNRF3 and RNF43 are active monomeric E3 ubiquitin ligases that self-associate. | Sci Signal | 2026 | 42378331 | PubTator, text mining | PubMed |
| Prostate Cancer: Etiology, Diagnosis, and Treatment. | Serican J Med | 2026 | 42375929 | PubTator, text mining | PubMed |
| Distinct immune responses to HIV and CMV in Hofbauer cells across gestation highlight evolving placental immune dynamics. | Front Immunol | 2026 | 42344922 | PubTator, text mining | PubMed |
| MHC Attention: Identifying HLA-E presented cancer antigens through deep learning and high-throughput screening. | bioRxiv | 2026 | 42327037 | PubTator, text mining | PubMed |
| An integrative mutational and network analysis of pancreatic cancer reveals key genes, and signalling pathways. | Funct Integr Genomics | 2026 | 42277390 | PubTator, text mining | PubMed |
| Functional precision oncology platform of BRAFV600E-mutated colorectal cancer organoids predicts therapy response and reveals RNF43-mediated immunogenicity. | Drug Resist Updat | 2026 | 42190325 | PubTator, text mining | PubMed |
| Identifying therapeutic target genes for stroke through systematic druggable Mendelian randomization analysis. | Medicine (Baltimore) | 2026 | 42116389 | PubTator, text mining | PubMed |
| RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged Survival in Pancreatic Adenocarcinoma. | Mod Pathol | 2026 | 42107534 | PubTator, text mining | PubMed |
| RNF43 deficiency activates YBX1-MYC-driven oxidative phosphorylation in pancreatic cancer. | Cancer Lett | 2026 | 42097492 | PubTator, text mining | PubMed |
| MSICKB: A Curated Knowledgebase for Exploring Molecular Heterogeneity and Biomarker Prioritization in Microsatellite Instability Cancers. | Comput Struct Biotechnol J | 2026 | 42017048 | PubTator, text mining | PubMed |
| Role of the cross-regulation between Wnt pathway activation and androgen receptor signaling in prostate cancer treatment resistance. | Cell Death Differ | 2026 | 41975070 | PubTator, text mining | PubMed |
| Molecular landscape and biomarker associations of functional NTRK fusions: a real-world retrospective cohort study across solid tumors. | Transl Cancer Res | 2026 | 41969448 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54894/papers